Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Only two of 156 scientific papers on AI published over the past 12 years used emotion as input data, according to a new literature review. And the reviewers focused on a specialty ripe for augmentation by artificial emotional intelligence: pregnancy health.
Psychological researchers have used AI to not only test a hypothesis on COVID-related behaviors but also to help come up with the hypothesis in the first place.
The healthcare AI startup founded by developers of the Apple Watch has been greenlit to market an AI-powered mobile application that lets radiologists interpret images and share the results with patients in real time.
When it comes to predicting an individual’s risk of suffering a heart attack or stroke over the next 10 years, machine learning models are no more consistent than traditional statistical techniques.
Leaders of the venture, dubbed “Project Amber,” are open-sourcing their technology and findings in the hope that other mental health researchers can take things from here.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.